Oxford Competitors

Pink Sheets . USA . 
Stock . Oxford BioDynamics Plc
OXBOF Stock  USD 0  0  150.00%   
Oxford BioDynamics Plc competes with Hookipa Pharma, and ImmunoCellular Therapeutics; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Oxford BioDynamics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Oxford BioDynamics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Oxford BioDynamics Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Oxford BioDynamics competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.00022.86
Details
Intrinsic
Valuation
LowRealHigh
0.00022.86
Details
Naive
Forecast
LowNextHigh
0.0001022.87
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.000200
Details

Oxford BioDynamics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Oxford BioDynamics and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Oxford and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Oxford BioDynamics Plc does not affect the price movement of the other competitor.

High positive correlations

CHMMF
+ 1.0
DVHGF
ANPCY
+ 0.57
NYMXF
ANPCY
+ 0.45
INTI
IMUC
+ 0.43
LIANY
INTI
+ 0.32
NYMXF
LVCLF
+ 0.26
HOOK
  

High negative correlations

CHMMF
- 1.0
QNNTF
QNNTF
- 1.0
DVHGF
NYMXF
- 0.67
LIANY
ANPCY
- 0.64
LIANY
ANPCY
- 0.46
LVCLF
INTI
- 0.32
LIANY

Risk-Adjusted Indicators

There is a big difference between Oxford Pink Sheet performing well and Oxford BioDynamics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oxford BioDynamics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
HOOK  1.32 (0.01) 0.00 (0.26) 0.00 
 0.00 
 3.45 
(3.30)
 8.99 
LIANY  5.75  1.16  0.10  3.16  6.30 
(11.18)
 12.73 
(11.76)
 60.61 
NYMXF  10.44  0.64  0.04  0.87  11.41 
(15.68)
 36.36 
(23.15)
 68.17 
LVCLF  1.84  0.55  0.00  1.39  0.00 
 0.00 
 0.00 
 0.00 
 61.22 
DVHGF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
QNNTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
CHMMF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
INTI  4.11  0.23  0.02  0.28  5.27 
(10.76)
 11.11 
(12.00)
 68.18 
IMUC  22.72  7.31  0.21  1.31  16.55 
(54.55)
 97.53 
(35.45)
 191.76 
ANPCY  10.80 (0.34) 0.00  0.17  0.00 
 0.00 
 34.78 
(26.67)
 145.07 
All Fundamental Data

Oxford BioDynamics Competitive Analysis

The better you understand Oxford BioDynamics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Oxford BioDynamics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Oxford BioDynamics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
OXBOF HOOK LIANY NYMXF LVCLF DVHGF QNNTF CHMMF INTI IMUC
 150.00 
 0 
Oxford
 2.25 
 0.91 
Hookipa
 3.26 
 0.1 
LianBio
 2.13 
 0.06 
Nymox
 0.00 
 0.01 
Living
 0.00 
 0.07 
Devonian
 0.00 
 0.10 
Quantum
 0.00 
 0 
Chimeric
 8.70 
 0.05 
Inhibitor
 5.00 
 0.19 
ImmunoCellular
Market Volatility
(90 Days Market Risk)
Out of control
Very risky
Out of control
Unknown risk
Out of control
Very steady
Very steady
Very steady
Out of control
Out of control
Market Performance
(90 Days Performance)
Weak
Weakest
Fair
Soft
Mild
Weakest
Weakest
Weakest
Soft
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Small
Small
Unknown
Unknown
Low
Small
Hazard
High
Small
High
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Current Ratio
2.98
5.48
17.84
9.07
3.01
N/A
0.04
1.51
Net Asset
11.34 M
82.55 M
4.27 M
21.59 M
22.59 M
34.88 M
58.78 K
N/A
Profit Margin
N/A
N/A
N/A
-1.67
N/A
N/A
N/A
N/A
EBITDA
(6.16 M)
(40.85 M)
(2.38 M)
(1.65 M)
(18.91 M)
(14.14 M)
(283.8 K)
(6.07 M)
Operating Margin
-55.85
-8.85
-428.7
-1.48
-5.48
-5.57
N/A
N/A
Current Valuation
37.52 M
(22.71 M)
12.53 M
42.9 M
(10.93 M)
56.81 K
26.98 M
(1.69 M)
Price To Book
0.19
0.38
6.96
2.75
7.49
1.49
76.91
0.35
Retained Earnings
N/A
(412.76 M)
(67 M)
N/A
N/A
N/A
(60.33 M)
(74.14 M)
Current Asset
N/A
26.61 M
6 M
N/A
N/A
N/A
2.39 M
24.56 M
Beta
1.21
0.9
0.27
1.22
0.27
N/A
-0.46
1.03
Number Of Employees
9
82
15
3
8
7
1
3
Shares Outstanding
146.71 M
9.93 M
1.29 B
134.69 M
34.53 M
437.09 M
376.86 M
4.19 M
Cash Flow From Operations
(5.18 M)
(76.98 M)
(2.04 M)
(2.87 M)
(17.02 M)
(13.15 M)
(220.43 K)
(2.31 M)
Total Debt
6.46 M
875 K
228.44 K
4.26 M
3 M
N/A
331 K
2.78 M
Return On Equity
-1.45
-1.06
-0.72
-0.33
-1.23
-0.63
N/A
-23.12
Z Score
3.0
N/A
5.4
4.8
23.4
N/A
N/A
-2.8
Return On Asset
-0.4
-0.45
-0.31
-0.12
-0.48
-0.26
-2.11
-4.4
Book Value Per Share
0.026
2.71
0.003
0.12
0.44
0.06
-0.021
-0.033
Number Of Shares Shorted
N/A
35.8 K
N/A
N/A
N/A
N/A
19.88 K
165.95 K
Current Liabilities
N/A
25.01 M
1000 K
N/A
N/A
N/A
736.4 K
2.27 M
Total Asset
11.34 M
82.55 M
4.27 M
21.59 M
22.59 M
34.88 M
58.78 K
30.08 M
Debt To Equity
0.99
0.052
0.1
0.31
0.14
N/A
11.81
0.39
Short Ratio
N/A
0.57
N/A
N/A
N/A
N/A
0.07
4.13
Target Price
N/A
2.0
N/A
N/A
N/A
N/A
N/A
5.0
Shares Owned By Institutions
52.68
12.16
N/A
N/A
3.69
N/A
N/A
N/A
Market Capitalization
37.41 M
10.97 M
9.81 M
36.79 M
117.4 M
26.23 M
22.99 M
2.21 M
Price To Earning
N/A
12.06
-31.67
N/A
N/A
N/A
-4.67
0.02
Price To Earnings To Growth
N/A
-0.19
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
198.91
1.17
5586.88
19.73
28.45
10.02
N/A
N/A
Net Income
(6.71 M)
(43.5 M)
(1.96 M)
(3.45 M)
(17.36 M)
(15.9 M)
(298.63 K)
(5.15 M)
Earnings Per Share
-0.088
-4.83
-0.002
N/A
-0.63
N/A
-0.001
28.91
Shares Owned By Insiders
30.93
0.12
33.99
7.81
9.18
47.75
79.33
94.96
Revenue
154 K
43.95 M
3.4 K
2.31 M
116.21 K
2.62 M
N/A
N/A
Working Capital
N/A
56.01 M
5 M
N/A
N/A
N/A
1.65 M
22.29 M
Cash And Equivalents
4.59 M
117.92 M
4.24 M
9.49 M
24.87 M
N/A
24.95 K
933.15 K
Cash Per Share
0.05
2.16
N/A
0.07
0.91
N/A
N/A
0.01
Gross Profit
116 K
(50.47 M)
3.4 K
561.01 K
(12.47 M)
2.62 M
N/A
N/A
Day Typical Price
0.0035
0.91
0.095
0.0597
0.0079
0.0711
0.1
0.001
0.05
0.16
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1231.58
Daily Balance Of Power
9.2 T
9.2 T
9.2 T
(9,223,372,036,855)
0.0
0.0
0.0
0.0
9.2 T
(0.11)
Period Momentum Indicator
0.0021
0.02
0.003
(0)
N/A
N/A
N/A
N/A
0.004
(0.01)
Rate Of Daily Change
2.5
1.02
1.03
0.98
1.0
1.0
1.0
1.0
1.09
0.95
Day Median Price
0.0035
0.91
0.095
0.0597
0.0079
0.0711
0.1
0.001
0.05
0.15
Price Action Indicator
0.0011
0.01
0.0015
(0.0006)
N/A
N/A
N/A
N/A
0.002
0.04
Relative Strength Index
44.71
53.64
52.92
47.12
85.61
N/A
N/A
N/A
54.89
53.06
Coefficient Of Variation
2021.36
(380,131)
788.42
2199.61
1363.37
N/A
N/A
N/A
2635.28
512.48
Mean Deviation
8.43
1.32
5.75
10.44
1.84
N/A
N/A
N/A
4.11
22.72
Jensen Alpha
1.45
(0.01)
1.16
0.6372
0.5499
N/A
N/A
N/A
0.2335
7.31
Total Risk Alpha
(1.24)
(0.19)
0.2482
(0.85)
(0.22)
N/A
N/A
N/A
(0.54)
3.79
Sortino Ratio
0.0299
N/A
0.0953
0.0403
N/A
N/A
N/A
N/A
0.0228
0.2131
Downside Variance
1421.96
N/A
137.18
238.87
N/A
N/A
N/A
N/A
112.37
1296.97
Standard Deviation
24.48
1.83
9.46
15.54
8.06
N/A
N/A
N/A
8.58
39.77
Kurtosis
22.85
0.2511
5.09
1.2
52.07
N/A
N/A
N/A
17.34
7.47
Potential Upside
12.16
3.45
12.73
36.36
N/A
N/A
N/A
N/A
11.11
97.53
Treynor Ratio
(0.35)
(0.26)
3.16
0.8677
1.39
N/A
N/A
N/A
0.2844
1.31
Maximum Drawdown
144.0
8.99
60.61
68.17
61.22
N/A
N/A
N/A
68.18
191.76
Variance
599.29
3.34
89.55
241.56
64.91
N/A
N/A
N/A
73.61
1581.37
Market Risk Adjusted Performance
(0.34)
(0.25)
3.17
0.8777
1.4
N/A
N/A
N/A
0.2944
1.32
Risk Adjusted Performance
0.0465
0.0057
0.1035
0.0433
0.0636
N/A
N/A
N/A
0.0373
0.1548
Skewness
3.62
(0.02)
0.9312
0.8982
6.4
N/A
N/A
N/A
2.69
2.38
Semi Deviation
11.77
N/A
6.3
11.41
N/A
N/A
N/A
N/A
5.27
16.55
Information Ratio
0.046
(0.05)
0.118
0.0401
0.0629
N/A
N/A
N/A
0.0282
0.193
Value At Risk
(25.56)
(3.30)
(11.76)
(23.15)
N/A
N/A
N/A
N/A
(12.00)
(35.45)
Expected Short fall
(70.74)
N/A
(11.18)
(15.68)
N/A
N/A
N/A
N/A
(10.76)
(54.55)
Downside Deviation
37.71
N/A
11.71
15.46
N/A
N/A
N/A
N/A
10.6
36.01
Semi Variance
138.63
N/A
39.66
130.09
N/A
N/A
N/A
N/A
27.76
273.83

Oxford BioDynamics Competition Performance Charts

Five steps to successful analysis of Oxford BioDynamics Competition

Oxford BioDynamics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Oxford BioDynamics Plc in relation to its competition. Oxford BioDynamics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Oxford BioDynamics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Oxford BioDynamics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Oxford BioDynamics Plc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Oxford BioDynamics position

In addition to having Oxford BioDynamics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Staples ETFs Thematic Idea Now

Consumer Staples ETFs
Consumer Staples ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Staples ETFs theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Staples ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Oxford Pink Sheet

Oxford BioDynamics financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford BioDynamics security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY